Diagnosis and Management of NREM Sleep Parasomnias in Children and Adults
Open accessThe DOI matches its Crossref record; 182 of the 193 references it cites were found in a registry or an index; 67 of the 245 sources its claims cite were checked for support.
Abstract
Non-rapid eye movement (NREM) sleep parasomnias are recurrent abnormal behaviors emerging as incomplete arousals out of NREM sleep. Mounting evidence on NREM sleep parasomnias calls for an update of clinical and therapeutical strategies. In the current review, we summarize the state of the art and provide the necessary background to stimulate a critical revision of diagnostic criteria of disorders of arousal (DoA), the most common NREM sleep parasomnia. In particular, we highlight the poor sensitivity of the diagnostic items related to amnesia and absence of conscious experiences during DoA episodes, encourage the role of video-polysomnography and home-video recordings in the diagnostic and treatment work-up, and suggest three levels of diagnostic certainty based on clinical and objective findings. Furthermore, we highlight current gaps of knowledge that prevent the definition of standard guidelines and future research avenues.
Overview
CoChat Summary
TL;DR
This narrative review updates diagnosis and management of NREM sleep parasomnias, focusing on disorders of arousal (DoA), sexsomnia, and sleep-related eating disorder (SRED). It argues that ICSD-3 amnesia/mental-content criteria should be supportive rather than mandatory and proposes three levels of diagnostic certainty plus a summary of pharmacological and non-pharmacological treatments.
Key findings
- DoA diagnostic criteria C/D regarding limited/absent cognition or dream imagery and amnesia fit poorly: mental recall has been reported in above 70% of patients across the lifespan and in ~60% of sleep-terror cases interviewed immediately after episodes; the authors suggest these should be optional supportive criteria, especially in children.
- VPSG captures a typical episode in approximately 30–60% of cases; home-video recordings are feasible, with an average of at least 3 nights required to capture at least 1 event, and the authors propose three diagnostic certainty levels: clinical, probable (home video and/or brief VPSG episodes), and definite (VPSG-documented full-blown DoA out of NREM sleep).
- Treatment evidence includes Clonazepam response rates of ~84% in 28 adults with SW/ST, ~75% in 57 DoA subjects, and ~72% in 173 of 350 NREM sleep parasomnia patients exposed to BDZ; L-OH-tryptophan in children with ST showed 94% efficacy at 1 month and 84% at 6 months; a CBTp randomized controlled trial improved parasomnia frequency, severity, and sleep continuity.
- Proposed VPSG indexes include SWS fragmentation index >6.8/h in adults (sensitivity 79%, specificity 82% for DoA vs HC), slow/mixed arousal index >2.5/h in adults (sensitivity 94%, specificity 68% for DoA vs HC), and eye opening during SWS interruptions ≥2 (sensitivity 94%, specificity 77% for DoA vs HC).
Methods
- Narrative review summarizing the state of the art on NREM sleep parasomnias, with primary aims to describe diagnostic evidence for DoA, summarize pharmacological and non-pharmacological treatments, discuss sexsomnia and SRED separately, and identify gaps preventing standard guidelines.
- Evidence base consists of published literature, including clinical series, video-polysomnography studies, questionnaire validation studies, and treatment reports; no primary data collection or systematic search strategy is stated.
- Synthesis is qualitative, with tables of diagnostic scales and VPSG indexes, and a proposal for updated DoA diagnostic criteria and three levels of diagnostic certainty.
Limitations
- The paper states that treatment evidence is hampered by few patients reaching specialist attention, lack of agreement between sleep centers, lack of animal models and clear neural-circuit understanding, and difficulty testing efficacy because of episode-related amnesia and low reliability of subjective reports; current therapies are mainly based on observational studies and case reports (low or very low quality of evidence by GRADE).
- The paper states that many objective VPSG indexes need validation against differential diagnoses such as SHE and sleep breathing disorders, and that larger blinded randomized studies and expert consensus are needed before standard guidelines can be defined.
- Evident from the text: as a narrative review without a stated systematic search or formal quality appraisal, selection and synthesis may be subject to bias, and the proposed diagnostic criteria are expert suggestions not yet validated by international consensus.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
46 Valid · 8 Not valid · 83 Not checked · 29 Own results and interpretations
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“An accurate clinical interview is theoretically sufficient to confirm a diagnosis of DoA according to standard international criteria [1,10]”
§ Diagnosis and Management of NREM Sleep Parasomnias in Children and Adults > 2. Diagnosis of DoA > 2.1. Clinical Interview
What the sources say
- Could not verifycites [1] American Academy of Sleep Medicine (2014). International Classification of Sleep Disorders, American Academy of Sleep Medicine. [3rd ed.]. sourceExperimental — accuracy not yet measured
The Abstract and 'The American Academy of Sleep Medicine' section address drowsy driving and recommend physician evaluation for drivers who struggle to stay awake. Searches for DoA, disorders of arousal, clinical interviews, and diagnostic criteria found no passage addressing whether an interview can confirm a DoA diagnosis. Page numbers were not available in our copy. (LLM, conf=0.78)
- Could not verifycites [10] American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Publishing. [5th ed.]. sourceExperimental — accuracy not yet measured
The supplied passages and searches for disorders of arousal, clinical interviews, and diagnostic criteria returned text about depression and WHO resources, not DoA diagnosis. No passage in our indexed copy addresses whether a clinical interview alone can confirm DoA under international criteria. (LLM, conf=0.74)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This percentage largely depends on the frequency/severity of parasomnia episodes, the life period when the recording is performed, the patient’s age, and the sensibility of the scorer to minor/brief nocturnal episodes [44,45,46,47]”
§ Diagnosis and Management of NREM Sleep Parasomnias in Children and Adults > 2. Diagnosis of DoA > 2.3. Video-Polysomnography
What the sources say
- Partly supportedcites [44] Drakatos, P., Marples, L., Muza, R., Higgins, S., Nesbitt, A., Dongol, E.M., Macavei, R., Gnoni, V., Carbonell, L.P., and Duncan, I. (2019). Video polysomnographic findings in non-rapid eye movement parasomnia. J. Sleep Res., 28. sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) suggests that the laboratory environment may alter the parasomnia events captured. The Limitations section (page unavailable) says that counting subtle behaviours affects the estimated diagnostic yield, which lends partial support to the point about scoring minor episodes. The paper does not establish that the percentage depends on episode frequency or severity, the life period of recording, or patient age; its age finding concerns coexisting sleep disorders instead. (LLM, conf=0.83)
- Not checked — no full text of the sourcecites [45] Lopez, 2018, Diagnostic criteria for disorders of arousal: A video-polysomnographic assessment, Ann. Neurol. source
- Partly supportedcites [46] Fois, 2015, The utility of polysomnography for the diagnosis of NREM parasomnias: An observational study over 4 years of clinical practice, J. Neurol. sourceExperimental — accuracy not yet measured
The Discussion (page not provided) links infrequent episodes to the difficulty of capturing events during polysomnography, supporting the frequency component. It does not establish that the percentage depends on episode severity, life period at recording, patient age, or scorer sensitivity to brief episodes. Its finding that age at onset did not affect detection does not test the separate claim about patient age. (LLM, conf=0.82)
- Not checked — no full text of the sourcecites [47] Zadra, 2008, Polysomnographic diagnosis of sleepwalking: Effects of sleep deprivation, Ann. Neurol. source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“SWS instability [3,31] recently demonstrated potential diagnostic validity through the definition of two indexes (the SWS fragmentation index and the slow/mixed arousal index) in both children and adults [45,72].”
§ Diagnosis and Management of NREM Sleep Parasomnias in Children and Adults > 2. Diagnosis of DoA > 2.3. Video-Polysomnography
What the sources say
- Not checked — no full text of the sourcecites [3] Zadra, 2013, Somnambulism: Clinical aspects and pathophysiological hypotheses, Lancet Neurol. source
- Not checked — no full text of the sourcecites [31] Pressman, 2007, Factors that predispose, prime and precipitate NREM parasomnias in adults: Clinical and forensic implications, Sleep Med. Rev. source
- Not checked — no full text of the sourcecites [45] Lopez, 2018, Diagnostic criteria for disorders of arousal: A video-polysomnographic assessment, Ann. Neurol. source
- Supportedcites [72] Lopez, 2021, Video-Polysomnographic Assessment for the Diagnosis of Disorders of Arousal in Children, Neurology source
The Conclusions (p. 2) identify the SWS fragmentation and slow/mixed arousal indexes as diagnostic biomarkers for disorders of arousal in children, with cutoffs different from those validated in adults. The Discussion (p. 9) also compares their diagnostic performance in children and adults. (LLM, conf=0.92)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“While the Z-drug Zolpidem has a relatively high risk of inducing a NREM parasomnia episode [6,96,97], especially in predisposed subjects”
§ Diagnosis and Management of NREM Sleep Parasomnias in Children and Adults > 2. Diagnosis of DoA > 2.6. Therapy
What the sources say
- Not checked — no full text of the sourcecites [6] Stallman, 2017, Medication induced sleepwalking: A systematic review, Sleep Med. Rev. source
- Partly supportedcites [96] Merino, D., Gérard, A.O., Van Obberghen, E.K., Ben Othman, N., Ettore, E., Giordana, B., Viard, D., Rocher, F., Destere, A., and Benoit, M. (2022). Medications as a Trigger of Sleep-Related Eating Disorder: A Disproportionality Analysis. J. Clin. Med., 11. sourceExperimental — accuracy not yet measured
The Results (§3.3; page unavailable) rank zolpidem first for disproportionate reporting of sleep-related eating disorder, and the Discussion (§4; page unavailable) says zolpidem has been found to increase the risk of other NREM parasomnias. The paper does not establish an absolute risk of an episode or show that the risk is especially high in predisposed subjects. (LLM, conf=0.84)
- Not checked — no full text of the sourcecites [97] Harbourt, 2020, Association of eszopiclone, zaleplon, or zolpidem with complex sleep behaviors resulting in serious injuries, including death, Pharmacoepidemiol. Drug Saf. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, the protocol of validation did not include a video-polysomnography (VPSG) to confirm the diagnosis, as this questionnaire was meant more for screening than for diagnostic purposes [32,33].”
§ Diagnosis and Management of NREM Sleep Parasomnias in Children and Adults > 2. Diagnosis of DoA > 2.2. Questionnaires
What the sources say
- Supportedcites [32] Fulda, 2008, Development and validation of the Munich Parasomnia Screening (MUPS), Somnologie source
The Procedure (p. 6) describes validation against interviews with clinical sleep experts, not video-polysomnography. The Discussion (p. 8) says the MUPS was designed for screening and does not claim to diagnose sleep-related disorders. (LLM, conf=0.91)
- Supportedcites [33] Komada, 2015, Japanese version of the Munich Parasomnia Screening: Translation and linguistic validation of a screening instrument for parasomnias and nocturnal behaviors, Neuropsychiatr. Dis. Treat. source
The Methods section describes the Japanese MUPS validation as translation, expert review, and cognitive debriefing, with no video-polysomnography or diagnostic confirmation in the reported protocol. The Introduction and Conclusion identify the instrument as a screening questionnaire. This supports the claim for the Japanese linguistic validation studied here, not necessarily for the original MUPS validation. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
84 more claims · 25 with their cited sources checked
Create a free account to see all 166 claims and every source verdict.
- It may state two separate claims as one. 64
- Probably not a substantial claim. 16
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Diagnosis and Management of NREM Sleep Parasomnias in Children and Adults > 2. Diagnosis of DoA > 2.6. Therapy
“The efficacy of Clonazepam was confirmed in 2012 by a retrospective study on 57 subjects affected by DoA, with a response rate of about 75% [101].”
§ Diagnosis and Management of NREM Sleep Parasomnias in Children and Adults > 2. Diagnosis of DoA > 2.6. Therapy
“In 2013, a large retrospective study on 103 patients described 6 patients effectively treated with non-pharmacological procedures that included sleep hygiene and behavioral intervention, deep relaxation, self-hypnosis, and rudiments of cognitive therapy [101].”
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
GRADE guidelines: 3. Rating the quality of evidence
Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285 · cited 1×
“Finally, in contrast with the many efforts devoted to the improvement of the diagnostic process, it should be highlighted that therapeutical strategies for NREM sleep parasomnias are still mainly based on observational studies and case reports (low or very low quality of evidence according to the GRADE system) [182].”
BackgroundKushida, C. A., Littner, M. R., Morgenthaler, T., Alessi, C. A., Bailey, D., Coleman, J., Friedman, L., Hirshkowitz, M., Kapen, S., Kramer, M., et al. (2005) · Sleep · doi:10.1093/sleep/28.4.499 · Cited by 2,054
Stunkard, A. J., Grace, W. J., & Wolff, H. G. (1955) · The American Journal of Medicine · doi:10.1016/0002-9343(55)90276-x · Cited by 612 · cited 1×
“obesity, morning anorexia (skipping breakfast), hyperphagia in the evening/night (eating more than half of daily calories after 7 PM), and insomnia [164].”
BackgroundDevelopment of Parasomnias From Childhood to Early Adolescence
Laberge, L., Tremblay, R. E., Vitaro, F., Montplaisir, J., & PhD, C. (2000) · Pediatrics · doi:10.1542/peds.106.1.67 · Cited by 427
Dyssomnias and Parasomnias in Early Childhood
Petit, D., Touchette, E., Tremblay, R. E., Boivin, M., & Montplaisir, J. (2007) · Pediatrics · doi:10.1542/peds.2006-2132 · Cited by 355
A polysomnographic and clinical report on sleep-related injury in 100 adult patients
(1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.9.1166 · Cited by 354 · cited 12×
“The efficacy of Clonazepam has also been occasionally described in some cases of DoA induced by neuroleptics [102] and in cases of sleep-driving and violent behaviors [16,100].”
BackgroundInfluentialBassetti, C., Vella, S., Donati, F., Wielepp, P., & Weder, B. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02561-7 · Cited by 351 · cited 1×
“Overall, the aforementioned quantitative EEG analysis of DoA episodes, while offering a deeper understating of DoA pathogenesis [2,65], has not been tested against potentially difficult differential diagnoses, such as SHE.”
BackgroundSchenck, C. H., & Mahowald, M. W. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)89493-4 · Cited by 291 · cited 13×
“The efficacy of Clonazepam has also been occasionally described in some cases of DoA induced by neuroleptics [102] and in cases of sleep-driving and violent behaviors [16,100].”
BackgroundResultInfluentialPressman, M. R. (2007) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2006.06.003 · Cited by 285 · cited 3×
“SWS instability [3,31] recently demonstrated potential diagnostic validity through the definition of two indexes (the SWS fragmentation index and the slow/mixed arousal index) in both children and adults [45,72].”
BackgroundSchenck, C. H., Arnulf, I., & Mahowald, M. W. (2007) · Sleep · doi:10.1093/sleep/30.6.683 · Cited by 235
Somnambulism: clinical aspects and pathophysiological hypotheses
Zadra, A., Desautels, A., Petit, D., & Montplaisir, J. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70322-8 · Cited by 229 · cited 1×
“SWS instability [3,31] recently demonstrated potential diagnostic validity through the definition of two indexes (the SWS fragmentation index and the slow/mixed arousal index) in both children and adults [45,72].”
BackgroundDerry, C. P., Harvey, A. S., Walker, M. C., Duncan, J. S., & Berkovic, S. F. (2009) · Sleep · doi:10.1093/sleep/32.12.1637 · Cited by 223 · cited 4×
“Indeed, the differential diagnosis of brief nocturnal episodes by both video and EEG is often extremely difficult [11].”
BackgroundInfluentialDistinguishing Sleep Disorders From Seizures: Diagnosing Bumps in the Night
Derry, C. P., Davey, M., Johns, M., Kron, K., Glencross, D., Marini, C., Scheffer, I. E., & Berkovic, S. F. (2006) · Archives of Neurology · doi:10.1001/archneur.63.5.705 · Cited by 223 · cited 2×
“FLEP [36] 62 adult and children/adolescent patients (31 with SHE, 29 with DoA, 2 with RBD) SHE: 100% SHE: 90% Differentiate SHE from parasomnias”
BackgroundMethodTerzaghi, M., Sartori, I., Tassi, L., Didato, G., Rustioni, V., LoRusso, G., Manni, R., & Nobili, L. (2009) · Sleep · doi:10.1093/sleep/32.3.409 · Cited by 222 · cited 1×
“Of note, delta activity increase seems to be inhomogeneous across the brain [58], and to coexist with an increase of higher frequencies in other brain regions [61] or even in the same brain region [57,58,62,63].”
BackgroundSelf-citationCAP, epilepsy and motor events during sleep: The unifying role of arousal
Parrino, L., Halasz, P., Tassinari, C. A., & Terzano, M. G. (2006) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2005.12.004 · Cited by 219 · cited 2×
“Strikingly, the slow arousal pattern somewhat corresponds to the A1 phase of the so-called cyclic alternating pattern (CAP) [74], an indirect measure of the arousal level fluctuations, which is known to be increased in DoA, especially in the first two sleep cycles [49,75,76].”
BackgroundEspa, F., Ondze, B., Deglise, P., Billiard, M., & Besset, A. (2000) · Clinical Neurophysiology · doi:10.1016/s1388-2457(00)00249-2 · Cited by 202 · cited 2×
“SWS temporal dynamics are also impaired, with an abnormal homeostatic build-up across the night [71] and a selective increase in the number of arousals/awakenings during SWS, not paralleled by a similar fragmentation in other sleep stages [26,45,66,71,72].”
BackgroundNREM sleep parasomnias as disorders of sleep-state dissociation
Castelnovo, A., Lopez, R., Proserpio, P., Nobili, L., & Dauvilliers, Y. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0030-y · Cited by 202 · cited 3×
“CA, ST, and SW should be interpreted as a diagnostic continuum on the basis of clinical, epidemiological, physiological, and genetic evidence [2].”
BackgroundSelf-citationDreamlike Mentations During Sleepwalking and Sleep Terrors in Adults
Oudiette, D., Leu, S., Pottier, M., Buzare, M.-A., Brion, A., & Arnulf, I. (2009) · Sleep · doi:10.1093/sleep/32.12.1621 · Cited by 196 · cited 1×
“However, this finding was not confirmed by other studies, which showed a substantially normal sleep macrostructure, comparable to healthy controls [7,18,24,45,49,51,67,68].”
ResultReview of nocturnal sleep-related eating disorders
Schenck, C. H., & Mahowald, M. W. (1994) · International Journal of Eating Disorders · doi:10.1002/eat.2260150405 · Cited by 196 · cited 1×
“The relationship between SRED and DoA is suggested by the fact that SRED patients display: (1) a high frequency of past or current SW, which is the predominant sleep disorder associated with night-eating [155]; (2) eating episodes during the first half of the night; (3) several arousals from SWS sleep [156]; (4) the a…”
BackgroundHLA and genetic susceptibility to sleepwalking
Lecendreux, M., Bassetti, C., Dauvilliers, Y., Mayer, G., Neidhart, E., & Tafti, M. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001203 · Cited by 193 · cited 1×
“Indeed, stress [12,123,124], emotional/behavioral problems, and personality traits have been linked to NREM sleep parasomnias [124–128], although the specific pathway and direction of this association remains unclear.”
BackgroundTinuper, P., Provini, F., Bisulli, F., Vignatelli, L., Plazzi, G., Vetrugno, R., Montagna, P., & Lugaresi, E. (2007) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2007.01.001 · Cited by 186 · cited 1×
“DoA must be differentiated by a number of other sleep disorders [81] (see Table 6): REM-related parasomnias, like nightmare disorder, RBD, and parasomnia overlap disorder [82].”
BackgroundSelf-citationSchenck, C. H., Hurwitz, T. D., Bundlie, S. R., & Mahowald, M. W. (1991) · Sleep · doi:10.1093/sleep/14.5.419 · Cited by 175 · cited 1×
“The first clinical series of SRED were described by the psychiatrist Carlos Schenck in 1991 (19 cases) and then 1993 (38 cases), who reported patients attending a sleep clinic for a combination of sleep and eating disorders [153,154].”
BackgroundAdult chronic sleepwalking and its treatment based on polysomnography
Guilleminault, C., Kirisoglu, C., Bao, G., Arias, V., Chan, A., & Li, K. K. (2005) · Brain · doi:10.1093/brain/awh481 · Cited by 174 · cited 2×
“While smaller clinical case series reported mixed results [94,98], larger studies showed stable and rather convincing results.”
BackgroundResultSomnambulism: All-Night Electroencephalographic Studies
Jacobson, A., Kales, A., Lehmann, D., & Zweizig, J. R. (1965) · Science · doi:10.1126/science.148.3672.975 · Cited by 171 · cited 1×
“However, this finding was not confirmed by other studies, which showed a substantially normal sleep macrostructure, comparable to healthy controls [7,18,24,45,49,51,67,68].”
ResultDynamics of slow-wave activity during the NREM sleep of sleepwalkers and control subjects
Gaudreau, H., Joncas, S., Zadra, A., & Montplaisir, J. (2000) · Sleep · doi:10.1093/sleep/23.6.1d · Cited by 169 · cited 1×
“SWS temporal dynamics are also impaired, with an abnormal homeostatic build-up across the night [71] and a selective increase in the number of arousals/awakenings during SWS, not paralleled by a similar fragmentation in other sleep stages [26,45,66,71,72].”
BackgroundParasomnias: An Updated Review
Howell, M. J. (2012) · Neurotherapeutics · doi:10.1007/s13311-012-0143-8 · Cited by 165
The value of sleep deprivation as a diagnostic tool in adult sleepwalkers
Joncas, S., Zadra, A., Paquet, J., & Montplaisir, J. (2002) · Neurology · doi:10.1212/wnl.58.6.936 · Cited by 159 · cited 3×
“However, this finding was not confirmed by other studies, which showed a substantially normal sleep macrostructure, comparable to healthy controls [7,18,24,45,49,51,67,68].”
BackgroundResultAdditional Categories of Sleep-Related Eating Disorders and the Current Status of Treatment
(1993) · Sleep · doi:10.1093/sleep/16.5.457 · Cited by 156 · cited 2×
“The first clinical series of SRED were described by the psychiatrist Carlos Schenck in 1991 (19 cases) and then 1993 (38 cases), who reported patients attending a sleep clinic for a combination of sleep and eating disorders [153,154].”
BackgroundZucconi, M., Oldani, A., Ferini‐Strambi, L., & Smirne, S. (1995) · PubMed · Cited by 155
Schenck, C. H., Pareja, J. A., Patterson, A. L., & Mahowald, M. W. (1998) · Journal of Clinical Neurophysiology · doi:10.1097/00004691-199803000-00010 · Cited by 153 · cited 2×
“The search for sleep trait abnormalities independent from clinical episodes has assumed particular relevance [55], as a single overnight in-laboratory VPSG is often negative for full-blown DoA episodes, or may allow the detection of only minor episodes undistinguishable from brief SHE episodes.”
BackgroundZucconi, M., Oldani, A., Ferini-Strambi, L., & Smirne, S. (1995) · Journal of Clinical Neurophysiology · doi:10.1097/00004691-199503000-00005 · Cited by 153 · cited 3×
“However, this finding was not confirmed by other studies, which showed a substantially normal sleep macrostructure, comparable to healthy controls [7,18,24,45,49,51,67,68].”
BackgroundResultVetrugno, R., Manconi, M., Ferini-Strambi, L., Provini, F., Plazzi, G., & Montagna, P. (2006) · Sleep · doi:10.1093/sleep/29.7.949 · Cited by 136 · cited 1×
“The relationship between SRED and DoA is suggested by the fact that SRED patients display: (1) a high frequency of past or current SW, which is the predominant sleep disorder associated with night-eating [155]; (2) eating episodes during the first half of the night; (3) several arousals from SWS sleep [156]; (4) the a…”
BackgroundSelf-citationPetit, D., Pennestri, M.-H., Paquet, J., Desautels, A., Zadra, A., Vitaro, F., Tremblay, R. E., Boivin, M., & Montplaisir, J. (2015) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2015.127 · Cited by 136 · cited 1×
“Another fundamental part in DoA clinical history is the identification of predisposing, priming, and precipitating factors like the familiar history [29], the presence of symptoms or signs suggestive for other sleep disorders known to fragment sleep (like sleep apneas or periodic limb movements), an unusual sleep envi…”
BackgroundUguccioni, G., Golmard, J.-L., de Fontréaux, A. N., Leu-Semenescu, S., Brion, A., & Arnulf, I. (2013) · Sleep Medicine · doi:10.1016/j.sleep.2013.01.014 · Cited by 131 · cited 13×
“Indeed, while negative emotions and violent behaviors are as frequent in DoA as in RBD [19], high levels of apprehension associated with misfortune (meaning any threat over which the subject does not have control) is more strictly associated with DoA than RBD. Self-defense or fleeing behaviors are more typical of DoA…”
BackgroundInfluentialSiclari, F., Khatami, R., Urbaniok, F., Nobili, L., Mahowald, M. W., Schenck, C. H., Cramer Bornemann, M. A., & Bassetti, C. L. (2010) · Brain · doi:10.1093/brain/awq296 · Cited by 131 · cited 2×
“Especially during adulthood, they could have variable consequences ranging from physical trauma, diurnal sleepiness [7,8], and psychological distress to legal issues due to violent/aggressive behaviors [9].”
BackgroundSelf-citationKavey, N. B., Whyte, J., Resor, S. R., & Gidro-Frank, S. (1990) · Neurology · doi:10.1212/wnl.40.5.749 · Cited by 130 · cited 3×
“, who described three patterns: (1) dramatic episodes with patients moving abruptly and impulsively in bed; (2) episodes characterized by sitting or kneeling on the bed; and (3) episodes with kicking or gesticulation [50].”
BackgroundResultThe value of sleep recording in evaluating somnambulism in young adults
Blatt, I., Peled, R., Gadoth, N., & Lavie, P. (1991) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(91)90058-c · Cited by 127 · cited 1×
“[48] 24 NS Sitting up in bed, performing semi-purposeful movements and gestures and lying down again; raising both legs in the air several times in the supine position; talking or screaming.”
BackgroundSleep and wakefulness in somnambulism
Guilleminault, C., Poyares, D., Abat, F., & Palombini, L. (2001) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(01)00187-8 · Cited by 125 · cited 1×
“However, this finding was not confirmed by other studies, which showed a substantially normal sleep macrostructure, comparable to healthy controls [7,18,24,45,49,51,67,68].”
ResultFunctional Impairment in Adult Sleepwalkers: A Case-Control Study
Lopez, R., Jaussent, I., Scholz, S., Bayard, S., Montplaisir, J., & Dauvilliers, Y. (2013) · Sleep · doi:10.5665/sleep.2446 · Cited by 123 · cited 1×
“Especially during adulthood, they could have variable consequences ranging from physical trauma, diurnal sleepiness [7,8], and psychological distress to legal issues due to violent/aggressive behaviors [9].”
BackgroundManni, R., Terzaghi, M., & Repetto, A. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01602.x · Cited by 121 · cited 4×
“6% of cases, which included patients with SHE seizures characterized by nocturnal wandering (mistaken for SW), while around one-third of cases had uncertain diagnostic indications, due to items associated with a risk of misdiagnosis (mainly “recall” and “clustering” of the events, increasing the chance of mistaking RB…”
BackgroundResultInfluentialHURWITZ, T. D., MAHOWALD, M. W., SCHENCK, C. H., SCHLUTER, J. L., & BUNDLIE, S. R. (1991) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199104000-00009 · Cited by 117 · cited 1×
“The efficacy of hypnotherapy was also observed in 2 larger case series of 27 [145] and 17 patients with SW and ST [146] that used a short hypnotherapy protocol (1–6 sessions and 1–2 sessions, respectively).”
BackgroundAssessment and treatment of nocturnal panic attacks
Craske, M. G., & Tsao, J. C. I. (2005) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2004.11.003 · Cited by 112
Medication induced sleepwalking: A systematic review
Stallman, H. M., Kohler, M., & White, J. (2018) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2017.01.005 · Cited by 112 · cited 2×
“While the Z-drug Zolpidem has a relatively high risk of inducing a NREM parasomnia episode [6,96,97], especially in predisposed subjects, low to moderate doses of benzodiazepines (BDZ)—and especially of the long-acting Clonazepam (0.”
BackgroundPolysomnographic diagnosis of sleepwalking: Effects of sleep deprivation
Zadra, A., Pilon, M., & Montplaisir, J. (2008) · Annals of Neurology · doi:10.1002/ana.21339 · Cited by 110
l -5-Hydroxytryptophan treatment of sleep terrors in children
Bruni, O., Ferri, R., Miano, S., & Verrillo, E. (2004) · European Journal of Pediatrics · doi:10.1007/s00431-004-1444-7 · Cited by 108
Schenck, C. H., & Mahowald, M. W. (1995) · Sleep · doi:10.1093/sleep/18.9.765 · Cited by 107 · cited 2×
“The efficacy of Clonazepam has also been occasionally described in some cases of DoA induced by neuroleptics [102] and in cases of sleep-driving and violent behaviors [16,100].”
BackgroundThe Use of Scheduled Awakenings to Eliminate Childhood Sleepwalking
Frank, N. C., Spirito, A., Stark, L., & Owens-Stively, J. (1997) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/22.3.345 · Cited by 100 · cited 1×
“When the occurrence of DoA episodes is highly predictable, arousing the patient 15–20 min prior to the usual onset of a typical episode for 1 to 4 weeks may induce sustained positive results, at least in children with SW [131], ST [132], or CA [133,134].”
BackgroundDreams and nightmares in healthy adults and in patients with sleep and neurological disorders
Siclari, F., Valli, K., & Arnulf, I. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30275-1 · Cited by 98 · cited 1×
“Moreover, the occurrence in at-home settings (and not in a virtual dreaming scenario as in RBD) seems to be very specific for DoA [23].”
BackgroundMason, T. B. A., & Pack, A. I. (2007) · Sleep · doi:10.1093/sleep/30.2.141 · Cited by 97 · cited 1×
“(1) reassurance regarding the absence of other associated severe neuropsychiatric conditions and the possible spontaneous resolution with age [15,91]; (2) instruction to parents/bed partners to refrain from interacting with/trying to awake the patient (to avoid worsening or lengthening the episodes or violent reaction…”
BackgroundThe treatment of parasomnias with hypnosis: A 5-year follow-up study
Hauri, P. J., Silber, M. H., & Boeve, B. F. (2007) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.26858 · Cited by 96 · cited 1×
“The efficacy of hypnotherapy was also observed in 2 larger case series of 27 [145] and 17 patients with SW and ST [146] that used a short hypnotherapy protocol (1–6 sessions and 1–2 sessions, respectively).”
BackgroundFulda, S., Hornyak, M., Müller, K., Cerny, L., Beitinger, P. A., & Wetter, T. C. (2008) · Somnologie - Schlafforschung und Schlafmedizin · doi:10.1007/s11818-008-0336-x · Cited by 95 · cited 4×
“Of note, neither MUPS or PADSS were validated against patients with SHE [35].”
MethodInfluentialDiagnostic criteria for disorders of arousal: A video-polysomnographic assessment
Lopez, R., Shen, Y., Chenini, S., Rassu, A. L., Evangelista, E., Barateau, L., Jaussent, I., & Dauvilliers, Y. (2018) · Annals of Neurology · doi:10.1002/ana.25153 · Cited by 92 · cited 16×
“Rhythmic and synchronous delta activity is preferentially associated with relatively simple and less complex behavioral episodes during SWS [60].”
BackgroundResultInfluentialAssociation of restless legs syndrome with nocturnal eating: A case-control study
Provini, F., Antelmi, E., Vignatelli, L., Zaniboni, A., Naldi, G., Calandra‐Buonaura, G., Vetrugno, R., Plazzi, G., & Montagna, P. (2009) · Movement Disorders · doi:10.1002/mds.22460 · Cited by 91
Self-citationSleep problems in pediatric practiceClinical issues for the pediatric nurse practitioner
MINDELL, J., & OWENS, J. (2003) · Journal of Pediatric Health Care · doi:10.1016/s0891-5245(03)00215-3 · Cited by 90 · cited 1×
“When the occurrence of DoA episodes is highly predictable, arousing the patient 15–20 min prior to the usual onset of a typical episode for 1 to 4 weeks may induce sustained positive results, at least in children with SW [131], ST [132], or CA [133,134].”
BackgroundFISHER, C., KAHN, E., EDWARDS, A., DAVIS, D. M., & FINE, J. (1974) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-197403000-00002 · Cited by 88
Provini, F., Albani, F., Vetrugno, R., Vignatelli, L., Lombardi, C., Plazzi, G., & Montagna, P. (2005) · European Journal of Neurology · doi:10.1111/j.1468-1331.2005.01017.x · Cited by 87 · cited 1×
“Among pharmacological options [154,162,166], Topiramate [163], dopaminergic agents [167], Clonazepam [168], and selective serotonin reuptake inhibitors (SSRI) such as Sertraline [169,170] should be considered.”
BackgroundSelf-citationGibbs, S. A., Proserpio, P., Francione, S., Mai, R., Cardinale, F., Sartori, I., Castana, L., Plazzi, G., Tinuper, P., Cossu, M., et al. (2019) · Epilepsia · doi:10.1111/epi.14690 · Cited by 87 · cited 1×
“These elements support the differential diagnosis with sleep-related hyper-motor epilepsy (SHE)—the condition that poses more challenging issues in terms of differential diagnosis, especially in the presence of short episodes [11,24,25].”
BackgroundSelf-citationA Scale for Assessing the Severity of Arousal Disorders
Arnulf, I., Zhang, B., Uguccioni, G., Flamand, M., de Fontréaux, A. N., Leu-Semenescu, S., & Brion, A. (2014) · Sleep · doi:10.5665/sleep.3322 · Cited by 84 · cited 3×
“The Paris Arousal Disorders Severity Scale (PADSS) [34] is a useful instrument for monitoring DoA clinical symptoms and severity.”
MethodPressman, M. R. (2004) · Sleep · doi:10.1093/sleep/27.4.706 · Cited by 83 · cited 1×
“Hyper-synchronous delta wave bursts are a relatively common finding, although with relatively low specificity [69].”
BackgroundSuccessful Treatment of Night Terrors and Somnambulism with Paroxetine
Lillywhite, A. R., Wilson, S. J., & Nutt, D. J. (1994) · British Journal of Psychiatry · doi:10.1192/bjp.164.4.551 · Cited by 81 · cited 4×
“As mentioned above, in a large retrospective study including 54 NREM sleep parasomnia patients treated with various AD (32% with Fluoxetine; 20% with Citalopram; 8% with Mirtazapine and Trimipramine; 7% with Amitriptyline, 5% with Paroxetine, Sertraline, Clomipramine, and Trazodone; and 5% with Imipramine and Venlafax…”
BackgroundInfluentialAdult night terrors and paroxetine
Nutt, D., Wilson, S., Lillywhite, A., Potokar, J., & Bell, C. (1997) · The Lancet · doi:10.1016/s0140-6736(05)62351-3 · Cited by 77 · cited 4×
“As mentioned above, in a large retrospective study including 54 NREM sleep parasomnia patients treated with various AD (32% with Fluoxetine; 20% with Citalopram; 8% with Mirtazapine and Trimipramine; 7% with Amitriptyline, 5% with Paroxetine, Sertraline, Clomipramine, and Trazodone; and 5% with Imipramine and Venlafax…”
BackgroundInfluentialSleep-related eating disorder versus sleepwalking: A controlled study
Brion, A., Flamand, M., Oudiette, D., Voillery, D., Golmard, J.-L., & Arnulf, I. (2012) · Sleep Medicine · doi:10.1016/j.sleep.2012.06.012 · Cited by 76 · cited 4×
“In addition, a VPSG case series on patients that satisfied clinical criteria of NES, described a nocturnal ingestion sub-type with a VPSG profile similar to SRED, with episodes occurring within 1 min from a NREM sleep awakening [156].”
BackgroundInfluentialJanuszko, P., Niemcewicz, S., Gajda, T., Wołyńczyk-Gmaj, D., Piotrowska, A. J., Gmaj, B., Piotrowski, T., & Szelenberger, W. (2016) · Clinical Neurophysiology · doi:10.1016/j.clinph.2015.01.014 · Cited by 74 · cited 1×
“Of note, delta activity increase seems to be inhomogeneous across the brain [58], and to coexist with an increase of higher frequencies in other brain regions [61] or even in the same brain region [57,58,62,63].”
BackgroundSleep-Related Eating Disorder and Night Eating Syndrome: Sleep Disorders, Eating Disorders, or Both?
Winkelman, J. W. (2006) · Sleep · doi:10.1093/sleep/29.7.876 · Cited by 72 · cited 3×
“However, many SRED patients can display various degrees of awareness, even during the same night [165], challenging the idea of a clear-cut distinction between SRED and NES.”
BackgroundInfluentialScalp and Source Power Topography in Sleepwalking and Sleep Terrors: A High-Density EEG Study
Castelnovo, A., Riedner, B. A., Smith, R. F., Tononi, G., Boly, M., & Benca, R. M. (2016) · Sleep · doi:10.5665/sleep.6162 · Cited by 72 · cited 1×
“Slow wave activity topographical distribution seems to be altered in patients compared to controls [70].”
BackgroundSelf-citationNREM parasomnias: A treatment approach based upon a retrospective case series of 512 patients
Drakatos, P., Marples, L., Muza, R., Higgins, S., Gildeh, N., Macavei, R., Dongol, E. M., Nesbitt, A., Rosenzweig, I., Lyons, E., et al. (2019) · Sleep Medicine · doi:10.1016/j.sleep.2018.03.021 · Cited by 72 · cited 17×
“The efficacy of Clonazepam has also been occasionally described in some cases of DoA induced by neuroleptics [102] and in cases of sleep-driving and violent behaviors [16,100].”
BackgroundResultInfluentialRemulla, A. T., & Guilleminault, C. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.10.2069 · Cited by 70
Analysis of postarousal EEG activity during somnambulistic episodes
Zadra, A., Pilon, M., Joncas, S., Rompré, S., & Montplaisir, J. (2004) · Journal of Sleep Research · doi:10.1111/j.1365-2869.2004.00404.x · Cited by 69 · cited 16×
“Rhythmic and synchronous delta activity is preferentially associated with relatively simple and less complex behavioral episodes during SWS [60].”
BackgroundInfluentialNonREM Disorders of Arousal and Related Parasomnias: An Updated Review
Irfan, M., Schenck, C. H., & Howell, M. J. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01011-y · Cited by 69
Sexsomnia: A Specialized Non-REM Parasomnia?
(2016) · Sleep · doi:10.1093/sleep/zsw043 · Cited by 66
NREM sleep instability in children with sleep terrors: The role of slow wave activity interruptions
Bruni, O., Ferri, R., Novelli, L., Finotti, E., Miano, S., & Guilleminault, C. (2008) · Clinical Neurophysiology · doi:10.1016/j.clinph.2008.01.015 · Cited by 64
Miyaoka, T., Yasukawa, R., Tsubouchi, K., Miura, S., Shimizu, Y., Sukegawa, T., Maeda, T., Mizuno, S., Kameda, A., Uegaki, J., et al. (2003) · International Clinical Psychopharmacology · doi:10.1097/00004850-200305000-00010 · Cited by 64 · cited 3×
“As mentioned above, in a large retrospective study including 54 NREM sleep parasomnia patients treated with various AD (32% with Fluoxetine; 20% with Citalopram; 8% with Mirtazapine and Trimipramine; 7% with Amitriptyline, 5% with Paroxetine, Sertraline, Clomipramine, and Trazodone; and 5% with Imipramine and Venlafax…”
BackgroundSleep Terror Disorder and Insomnia Treated with Trazodone: A Case Report
Balon, R. (1994) · Annals of Clinical Psychiatry · doi:10.3109/10401239409148998 · Cited by 64 · cited 2×
“As mentioned above, in a large retrospective study including 54 NREM sleep parasomnia patients treated with various AD (32% with Fluoxetine; 20% with Citalopram; 8% with Mirtazapine and Trimipramine; 7% with Amitriptyline, 5% with Paroxetine, Sertraline, Clomipramine, and Trazodone; and 5% with Imipramine and Venlafax…”
BackgroundRestless Nocturnal Eating: A Common Feature of Willis-Ekbom Syndrome (RLS)
Howell, M. J., & Schenck, C. H. (2012) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.2036 · Cited by 63
Treatment of Sleepwalking: A Controlled Study
Reid, W. H., Ahmed, I., & Levie, C. A. (1981) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1981.35.1.27 · Cited by 63 · cited 1×
“One single-blind (rater-blind), modified crossover design study evaluating a brief protocol (6 sessions) of specialized hypnotherapy for severe SW, free from other psychiatric illness, revealed a long-lasting improvement in both subjective and objective symptoms at 1-year follow-up [147].”
MethodSleepwalking, sleep terrors, sexsomnia and other disorders of arousal: the old and the new
Idir, Y., Oudiette, D., & Arnulf, I. (2022) · Journal of Sleep Research · doi:10.1111/jsr.13596 · Cited by 61 · cited 2×
“Conversely, mounting evidence is available regarding DoA clinical, phenomenological, and physiological correlates [2,4].”
BackgroundParoxetine-induced somnambulism
Kawashima, T., & Yamada, S. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0420e · Cited by 59 · cited 1×
“Fewer and sometimes contradictory cases have been reported regarding Paroxetine in SW, with Paroxetine potentially resolving [111,112] or inducing [113] SW.”
BackgroundBaldini, T., Loddo, G., Sessagesimi, E., Mignani, F., Cirignotta, F., Mondini, S., Licchetta, L., Bisulli, F., Tinuper, P., & Provini, F. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00526 · Cited by 57 · cited 4×
“Last but not least, DoA episodes usually occur in clusters across the life span, with a frequency of episodes that fluctuates over time, possibly in relation to sleep deprivation and stress [12].”
BackgroundInfluentialSelf-citationDesjardins, M.-È., Carrier, J., Lina, J.-M., Fortin, M., Gosselin, N., Montplaisir, J., & Zadra, A. (2017) · Sleep · doi:10.1093/sleep/zsx024 · Cited by 56
Parasomnias and Antidepressant Therapy: A Review of the Literature
Kierlin, L., & Littner, M. R. (2011) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2011.00071 · Cited by 55
(1987) · PubMed · Cited by 54
Two cases of premenstrual sleep terrors and injurious sleep-walking
Schenck, C. H., & Mahowald, M. W. (1995) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.3109/01674829509042782 · Cited by 54 · cited 1×
“Hypnotherapy received specific attention since the earliest definition of DoA, with case reports and small case series on SW in adults [138,139], ST or other complex dangerous behaviors in children [140–143], and more recently, even in a case of childhood parasomnia overlap disorder (POD) [144].”
BackgroundAdult NREM Parasomnias: An Update
Hrozanova, M., Morrison, I., & Riha, R. L. (2018) · Clocks & Sleep · doi:10.3390/clockssleep1010009 · Cited by 54
Stefani, A., Gabelia, D., Mitterling, T., Poewe, W. H., Högl, B., & Frauscher, B. (2015) · SLEEP · doi:10.5665/sleep.4994 · Cited by 52 · cited 1×
“All in all, the identification of distinctive motor signatures in sleep disorders requires larger studies as well as comparison with physiological movements and arousals of healthy sleepers, analytically characterized only in a few studies so far [53,54].”
BackgroundObjective daytime sleepiness in patients with somnambulism or sleep terrors
Lopez, R., Jaussent, I., & Dauvilliers, Y. (2014) · Neurology · doi:10.1212/wnl.0000000000001019 · Cited by 50 · cited 2×
“However, this finding was not confirmed by other studies, which showed a substantially normal sleep macrostructure, comparable to healthy controls [7,18,24,45,49,51,67,68].”
BackgroundResultSleepwalking: Long-term home video monitoring
Mwenge, B., Brion, A., Uguccioni, G., & Arnulf, I. (2013) · Sleep Medicine · doi:10.1016/j.sleep.2013.04.027 · Cited by 50 · cited 1×
“Up to now, 2 single case reports highlighted the usefulness of monitoring nocturnal behaviors in adults with NREM sleep parasomnias with an infrared camera in the home environment for 5 and 2 weeks, respectively [21,79].”
BackgroundLoddo, G., Sessagesimi, E., Mignani, F., Cirignotta, F., Mondini, S., Licchetta, L., Bisulli, F., Tinuper, P., & Provini, F. (2018) · Sleep Medicine · doi:10.1016/j.sleep.2017.08.019 · Cited by 50 · cited 2×
“A more recent study on 45 patients (334 DoA events) proposed a different hierarchical classification of increasing motor complexity [12,52]: (1) simple arousal movements (SAMs); (2) rising arousal movements (RAMs or pattern II); and (3) complex arousal movements (CAMs or pattern III) (see Table 4).”
BackgroundSelf-citationPain in Sleepwalking: A Clinical Enigma
Lopez, R., Jaussent, I., & Dauvilliers, Y. (2015) · Sleep · doi:10.5665/sleep.5144 · Cited by 49 · cited 1×
“Notably, the arousal threshold is higher than wakefulness, and pain processing seems to be altered [17], further exposing these patients to potential dangers.”
BackgroundTreatment Options for Parasomnias
Attarian, H. P. (2010) · Neurologic Clinics · doi:10.1016/j.ncl.2010.03.025 · Cited by 49 · cited 1×
“, regular sleep-wake routine, quiet and dark bedroom environment, avoidance of sleep deprivation, or of excessive alcohol intake) [31,92]; (4) specific instructions for environmental safety (removal of firearms or other weapons from home, removal of any bedside object or furniture that could cause injuries, installati…”
BackgroundProserpio, P., Loddo, G., Zubler, F., Ferini-Strambi, L., Licchetta, L., Bisulli, F., Tinuper, P., Agostoni, E. C., Bassetti, C., Tassi, L., et al. (2019) · Sleep · doi:10.1093/sleep/zsz166 · Cited by 48 · cited 6×
“Major event outside N3 [28] ≥1 79% 95% SHE vs DoA”
BackgroundInfluentialSelf-citationTreatment of Sleep-Related Eating Disorder
Chiaro, G., Caletti, M. T., & Provini, F. (2015) · Current Treatment Options in Neurology · doi:10.1007/s11940-015-0361-6 · Cited by 46 · cited 3×
“The relationship between SRED and DoA is suggested by the fact that SRED patients display: (1) a high frequency of past or current SW, which is the predominant sleep disorder associated with night-eating [155]; (2) eating episodes during the first half of the night; (3) several arousals from SWS sleep [156]; (4) the a…”
BackgroundResultSelf-citationBupropion-induced somnambulism
KHAZAAL, Y., KRENZ, S., & ZULLINO, D. F. (2003) · Addiction Biology · doi:10.1080/13556210310001602284 · Cited by 46 · cited 1×
“The appearance of SW has also been associated with other AD, like Bupropion [114,115], Mirtazapine [116], and Reboxetine [117].”
BackgroundHarbourt, K., Nevo, O. N., Zhang, R., Chan, V., & Croteau, D. (2020) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5004 · Cited by 46
Sleep-Terror Disorder in Children: The Role of Self-Hypnosis in Management
Kohen, D. P., Mahowald, M. W., & Rosen, G. M. (1992) · American Journal of Clinical Hypnosis · doi:10.1080/00029157.1992.10402853 · Cited by 44
Treatment options for disorders of arousal: A case series
Attarian, H., & Zhu, L. (2013) · International Journal of Neuroscience · doi:10.3109/00207454.2013.783579 · Cited by 44 · cited 6×
“As mentioned above, in a large retrospective study including 54 NREM sleep parasomnia patients treated with various AD (32% with Fluoxetine; 20% with Citalopram; 8% with Mirtazapine and Trimipramine; 7% with Amitriptyline, 5% with Paroxetine, Sertraline, Clomipramine, and Trazodone; and 5% with Imipramine and Venlafax…”
BackgroundResultInfluentialA child with severe night terrors and sleep-walking responds to melatonin therapy
Jan, J., Freeman, R., Wasdell, M., & Bomben, M. (2004) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2004.tb01003.x · Cited by 44 · cited 1×
“Melatonin has been anecdotally reported to be effective in younger children (1 case in a 36-month-old child with ST [119]), including syndromic cases (1 child affected by Asperger syndrome and 1 child with a chronic sleep-phase onset delay [120]).”
BackgroundThe parasomnias: Mechanisms and treatment
Tinuper, P., Bisulli, F., & Provini, F. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03710.x · Cited by 43
Self-citationFois, C., Wright, M.-A. S., Sechi, G., Walker, M. C., & Eriksson, S. H. (2015) · Journal of Neurology · doi:10.1007/s00415-014-7578-2 · Cited by 42
Loddo, G., Baldassarri, L., Zenesini, C., Licchetta, L., Bisulli, F., Cirignotta, F., Mondini, S., Tinuper, P., & Provini, F. (2020) · Epilepsia · doi:10.1111/epi.16659 · Cited by 42 · cited 5×
“The characterization of their duration (a median of 12 s versus 5), sleep stage at onset (NREM stage N3 vs N1/N2), movement progression (waxing and waning versus continuous), and associated behaviors, such as exploratory behaviors, are important to differentiate DoA from SHE [24].”
BackgroundResultInfluentialSelf-citationConfusional arousals during non-rapid eye movement sleep: evidence from intracerebral recordings
Flamand, M., Boudet, S., Lopes, R., Vignal, J.-P., Reyns, N., Charley-Monaca, C., Peter-Derex, L., & Szurhaj, W. (2018) · Sleep · doi:10.1093/sleep/zsy139 · Cited by 41
Treatment of nocturnal eating disorders
Howell, M. J., & Schenck, C. H. (2009) · Current Treatment Options in Neurology · doi:10.1007/s11940-009-0037-1 · Cited by 38 · cited 1×
“Among pharmacological options [154,162,166], Topiramate [163], dopaminergic agents [167], Clonazepam [168], and selective serotonin reuptake inhibitors (SSRI) such as Sertraline [169,170] should be considered.”
BackgroundZadra, A., & Pilon, M. (2011) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-52007-4.00011-4 · Cited by 38
Hypnosis in the Management of Sleep Disorders
Becker, P. M. (2015) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2014.11.003 · Cited by 37
Hypersynchronous Slow Delta, Cyclic Alternating Pattern and Sleepwalking
(2006) · Sleep · doi:10.1093/sleep/29.1.14 · Cited by 36 · cited 1×
“Strikingly, the slow arousal pattern somewhat corresponds to the A1 phase of the so-called cyclic alternating pattern (CAP) [74], an indirect measure of the arousal level fluctuations, which is known to be increased in DoA, especially in the first two sleep cycles [49,75,76].”
BackgroundDisorders of Arousal in adults: New diagnostic tools for clinical practice
Loddo, G., Lopez, R., Cilea, R., Dauvilliers, Y., & Provini, F. (2019) · Sleep Science and Practice · doi:10.1186/s41606-019-0037-3 · Cited by 36 · cited 1×
“Another fundamental part in DoA clinical history is the identification of predisposing, priming, and precipitating factors like the familiar history [29], the presence of symptoms or signs suggestive for other sleep disorders known to fragment sleep (like sleep apneas or periodic limb movements), an unusual sleep envi…”
BackgroundSelf-citationClonazepam in the Treatment of Neuroleptic-Induced Somnambulism
GOLDBLOOM, D., & Chouinard, G. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.11.aj141111486 · Cited by 34
Video polysomnographic findings in non‐rapid eye movement parasomnia
Drakatos, P., Marples, L., Muza, R., Higgins, S., Nesbitt, A., Dongol, E. M., Macavei, R., Gnoni, V., Perez Carbonell, L., Duncan, I., et al. (2019) · Journal of Sleep Research · doi:10.1111/jsr.12772 · Cited by 34 · cited 1×
“Furthermore, VPSG traces can give important information regarding other potential sleep disorders triggering DoA, such as obstructive sleep apneas and periodic limb movements (PLM) (up to 33% of the cases in adults) [44].”
BackgroundMutti, C., Bernabè, G., Barozzi, N., Ciliento, R., Trippi, I., Pedrazzi, G., Azzi, N., & Parrino, L. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.600026 · Cited by 34 · cited 1×
“In order to be included in standard clinical practice, these indexes need to be validated versus other sleep pathological conditions, such as sleep breathing disorders or SHE, where sleep instability and CAP rate has been proven to be even higher than DoA [77].”
BackgroundClonazepam in the treatment of neuroleptic-induced somnambulism
GOLDBLOOM, D., & CHOUINARD, G. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.11.1486 · Cited by 34 · cited 1×
“The efficacy of Clonazepam has also been occasionally described in some cases of DoA induced by neuroleptics [102] and in cases of sleep-driving and violent behaviors [16,100].”
BackgroundDiazepam in intractable sleepwalking: a pilot study.
Reid, W. H., Haffke, E. A., & Chu, C.-C. (1984) · PubMed · Cited by 33
Winkelman, J. W., Johnson, E. A., & Richards, L. M. (2011) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-52006-7.00037-x · Cited by 33
Abnormal timing of slow wave synchronization processes in non-rapid eye movement sleep parasomnias
Cataldi, J., Stephan, A. M., Marchi, N. A., Haba-Rubio, J., & Siclari, F. (2022) · Sleep · doi:10.1093/sleep/zsac111 · Cited by 33 · cited 1×
“This pattern does not seem to differ between simpler or complex DoA behaviors [57], and qualitatively resembles the pattern observed prior to physiological arousals—although perhaps richer in SWA and poorer of higher (beta) activity [59].”
BackgroundMuza, R., Lawrence, M., & Drakatos, P. (2016) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000321 · Cited by 32
Simple behavioral criteria for the diagnosis of disorders of arousal
Barros, A., Uguccioni, G., Salkin-Goux, V., Leu-Semenescu, S., Dodet, P., & Arnulf, I. (2020) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.8136 · Cited by 32 · cited 5×
“SWS temporal dynamics are also impaired, with an abnormal homeostatic build-up across the night [71] and a selective increase in the number of arousals/awakenings during SWS, not paralleled by a similar fragmentation in other sleep stages [26,45,66,71,72].”
BackgroundInfluentialTopiramate reduces nocturnal eating in sleep-related eating disorder
Winkelman, J. W., Wipper, B., Purks, J., Mei, L., & Schoerning, L. (2020) · Sleep · doi:10.1093/sleep/zsaa060 · Cited by 32 · cited 3×
“The relationship between SRED and DoA is suggested by the fact that SRED patients display: (1) a high frequency of past or current SW, which is the predominant sleep disorder associated with night-eating [155]; (2) eating episodes during the first half of the night; (3) several arousals from SWS sleep [156]; (4) the a…”
BackgroundResultThe Co-Occurrence of Sexsomnia, Sleep Bruxism and Other Sleep Disorders
Martynowicz, H., Smardz, J., Wieczorek, T., Mazur, G., Poreba, R., Skomro, R., Zietek, M., Wojakowska, A., Michalek, M., & Wieckiewicz, M. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7090233 · Cited by 31 · cited 1×
“Comorbid sleep conditions that may act as triggers for sexsomnia episodes include obstructive sleep apneas, PLM, sleep bruxism, or even sleep-related head jerks [173,174,177,178].”
BackgroundGurbani, N. S., Dye, T. J., Dougherty, K., Jain, S. V., Horn, P. S., & Simakajornboon, N. (2019) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.7766 · Cited by 31 · cited 1×
“, regular sleep-wake routine, quiet and dark bedroom environment, avoidance of sleep deprivation, or of excessive alcohol intake) [31,92]; (4) specific instructions for environmental safety (removal of firearms or other weapons from home, removal of any bedside object or furniture that could cause injuries, installati…”
BackgroundCan Homemade Video Recording Become More Than a Screening Tool?
Nobili, L. (2009) · Sleep · doi:10.1093/sleep/32.12.1544 · Cited by 30 · cited 4×
“VPSG assumes an important role in the differential diagnosis between DoA and SHE [35], RBD or parasomnia overlap disorder [42], as well as in sleep-related (psychogenic) dissociative disorders [43].”
BackgroundMethodInfluentialSelf-citationSleepwalking: Diagnosis and treatment through the life cycle
Berlin, R. M., & Qayyum, U. (1986) · Psychosomatics · doi:10.1016/s0033-3182(86)72602-9 · Cited by 30 · cited 1×
“More anecdotical and sometimes contradictory results are available for other BDZ, like Alprazolam [100,101], Triazolam [103], Temazepam [101], Flurazepam [50], Clorazepate [104], and Diazepam [104–106].”
ResultCastelnovo, A., Loddo, G., Provini, F., Miano, S., & Manconi, M. (2021) · Nature and Science of Sleep · doi:10.2147/nss.s309868 · Cited by 28 · cited 1×
“Of note, the recall rate seems to differ between children and adults, in line with the hypotheses of more immature sleep mechanisms in children (and lower dream recall rate), and with an easier arousability in adults (that may facilitate the incorporation of the dream experience in longterm memory) [5,20].”
ResultSelf-citationNew Onset Somnambulism Associated With Different Dosage of Mirtazapine: A Case Report
Yeh, Y.-W., Chen, C.-H., Feng, H.-M., Wang, S.-C., Kuo, S.-C., & Chen, C.-K. (2009) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e318187bafc · Cited by 27 · cited 2×
“As mentioned above, in a large retrospective study including 54 NREM sleep parasomnia patients treated with various AD (32% with Fluoxetine; 20% with Citalopram; 8% with Mirtazapine and Trimipramine; 7% with Amitriptyline, 5% with Paroxetine, Sertraline, Clomipramine, and Trazodone; and 5% with Imipramine and Venlafax…”
BackgroundHigh-density EEG power topography and connectivity during confusional arousal
Castelnovo, A., Amacker, J., Maiolo, M., Amato, N., Pereno, M., Riccardi, S., Danani, A., Ulzega, S., & Manconi, M. (2022) · Cortex · doi:10.1016/j.cortex.2022.05.021 · Cited by 27 · cited 3×
“Of note, delta activity increase seems to be inhomogeneous across the brain [58], and to coexist with an increase of higher frequencies in other brain regions [61] or even in the same brain region [57,58,62,63].”
BackgroundSelf-citationHome nocturnal infrared video to record non‐rapid eye movement sleep parasomnias
Lopez, R., Barateau, L., Chenini, S., Rassu, A. L., & Dauvilliers, Y. (2023) · Journal of Sleep Research · doi:10.1111/jsr.13732 · Cited by 26 · cited 3×
“In particular, it will be fundamental to improve motion tracking, to secure online data storage, to develop a dedicated software for scoring video events, and portable home-EEG devices coupled with infrared video cameras [80].”
BackgroundResultPerogamvros, L., Aberg, K., Gex-Fabry, M., Perrig, S., Cloninger, C. R., & Schwartz, S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0134504 · Cited by 25
Sleep-Related Hypermotor Epilepsy vs Disorders of Arousal in Adults
Montini, A., Loddo, G., Baldelli, L., Cilea, R., & Provini, F. (2021) · Chest · doi:10.1016/j.chest.2021.01.059 · Cited by 25 · cited 5×
“VPSG assumes an i portant role in the differential diagnosis between DoA and SHE [35], RBD or parasomnia overlap disorder [42], as well as in sleep-related (psychogenic) dissociative disorders [43].”
BackgroundMethodInfluentialSelf-citationHypnotic Treatment of Sleep Terror Disorder: A Case Report
Koe, G. G. (1989) · American Journal of Clinical Hypnosis · doi:10.1080/00029157.1989.10402794 · Cited by 24
Melatonin Treatment for Childhood Sleep Terror
Özcan, Ö., & Dönmez, Y. E. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2014.0061 · Cited by 23
Effective Treatment of Night Terrors and Sleepwalking with Ramelteon
Sasayama, D., Washizuka, S., & Honda, H. (2016) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2016.0088 · Cited by 23 · cited 1×
“Only one case report is available on Ramelteon, a Melatonin receptor agonist, which resulted effectively in a boy with attention-deficit/hyperactivity disorder (ADHD) and ST/SW [121].”
BackgroundBehavioural and emotional profiles of children and adolescents with disorders of arousal
Castelnovo, A., Turner, K., Rossi, A., Galbiati, A., Gagliardi, A., Proserpio, P., Nobili, L., Terzaghi, M., Manni, R., Ferini Strambi, L., et al. (2021) · Journal of Sleep Research · doi:10.1111/jsr.13188 · Cited by 23 · cited 1×
“Indeed, stress [12,123,124], emotional/behavioral problems, and personality traits have been linked to NREM sleep parasomnias [124–128], although the specific pathway and direction of this association remains unclear.”
BackgroundSelf-citationBupropion-Induced Sleepwalking
Oulis, P., Kokras, N., Papadimitriou, G. N., & Masdrakis, V. G. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181c9c8a2 · Cited by 22 · cited 1×
“The appearance of SW has also been associated with other AD, like Bupropion [114,115], Mirtazapine [116], and Reboxetine [117].”
BackgroundAttenuation of drug-induced anxiety dreams and pavor nocturnus by benzodiazepines.
Rm, A. (1983) · PubMed · Cited by 22
Non-Rapid Eye Movement Arousal Parasomnias in Children
Ekambaram, V., & Maski, K. P. (2017) · Pediatric Annals · doi:10.3928/19382359-20170814-01 · Cited by 22
Schenck, C. H., Cramer Bornemann, M., Kaplish, N., & Eiser, A. S. (2021) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.9048 · Cited by 22 · cited 2×
“VPSG assumes an important role in the differential diagnosis between DoA and SHE [35], RBD or parasomnia overlap disorder [42], as well as in sleep-related (psychogenic) dissociative disorders [43].”
BackgroundEEG Patterns Prior to Motor Activations of Parasomnias: A Systematic Review
Camaioni, M., Scarpelli, S., Gorgoni, M., Alfonsi, V., & De Gennaro, L. (2021) · Nature and Science of Sleep · doi:10.2147/nss.s306614 · Cited by 22 · cited 3×
“SWA connectivity also drastically changes prior and during DoA episodes [58,64].”
BackgroundTreatment of Somnambulism in Military Trainees
Reid, W. H. (1975) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1975.29.1.101 · Cited by 21 · cited 1×
“Hypnotherapy received specific attention since the earliest definition of DoA, with case reports and small case series on SW in adults [138,139], ST or other complex dangerous behaviors in children [140–143], and more recently, even in a case of childhood parasomnia overlap disorder (POD) [144].”
BackgroundUpdate on nonpharmacological interventions in parasomnias
Ntafouli, M., Galbiati, A., Gazea, M., Bassetti, C. L., & Bargiotas, P. (2019) · Postgraduate Medicine · doi:10.1080/00325481.2019.1697119 · Cited by 21 · cited 1×
“Psychotherapy may help them increasing the awareness for their dysfunctional beliefs and in managing the emotional distress/conflicts over their own judgments [130].”
BackgroundPsychological Treatment for Sleepwalking: Two case reports
Conway, S. G., Castro, L., Lopes-Conceição, M. C., Hachul, H., & Tufik, S. (2011) · Clinics · doi:10.1590/s1807-59322011000300028 · Cited by 20 · cited 1×
“The efficacy of other relaxation techniques such as autogenic training and the psychodynamic approach to emotional conflicts (related to parasomnia behaviors themselves or external factors, considered as triggers of parasomnia episodes) have been sporadically reported [148,149].”
BackgroundContreras, J. B., Richardson, J., & Kotagal, S. (2019) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.7686 · Cited by 20 · cited 2×
“In some cases, the resolution of comorbid sleep apneas was sufficient to obtain full remission [174,180,181], while other cases required a multi-modal therapeutical approach, including pharmacotherapy, cognitive behavioral therapy, and hypnosis [179].”
BackgroundCock, V. C. D. (2016) · Current Treatment Options in Neurology · doi:10.1007/s11940-015-0388-8 · Cited by 20
Night Terrors in a Child Treated with Hypnosis
Taboada, E. L. (1975) · American Journal of Clinical Hypnosis · doi:10.1080/00029157.1975.10403756 · Cited by 19
Disorders of Arousal: A Chronobiological Perspective
Mainieri, G., Loddo, G., & Provini, F. (2021) · Clocks & Sleep · doi:10.3390/clockssleep3010004 · Cited by 19
Self-citationNakamura, M., Sugiura, T., Nishida, S., Komada, Y., & Inoue, Y. (2013) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.2666 · Cited by 18
Künzel, H. E., Schuld, A., & Pollmächer, T. (2004) · Pharmacopsychiatry · doi:10.1055/s-2004-832692 · Cited by 18
Two Cases of Sleep-Related Eating Disorder Responding Promptly to Low-Dose Sertraline Therapy
Varghese, R., Rey de Castro, J., Liendo, C., & Schenck, C. H. (2018) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.7404 · Cited by 18 · cited 3×
“As mentioned above, in a large retrospective study including 54 NREM sleep parasomnia patients treated with various AD (32% with Fluoxetine; 20% with Citalopram; 8% with Mirtazapine and Trimipramine; 7% with Amitriptyline, 5% with Paroxetine, Sertraline, Clomipramine, and Trazodone; and 5% with Imipramine and Venlafax…”
BackgroundVideo-Polysomnographic Assessment for the Diagnosis of Disorders of Arousal in Children
Lopez, R., Laganière, C., Chenini, S., Rassu, A. L., Evangelista, E., Barateau, L., Jaussent, I., & Dauvilliers, Y. (2021) · Neurology · doi:10.1212/wnl.0000000000011091 · Cited by 18
Castelnovo, A., Loddo, G., Provini, F., & Manconi, M. (2021) · Sleep Medicine · doi:10.1016/j.sleep.2021.03.032 · Cited by 18 · cited 2×
“Up to now, 2 single case reports highlighted the usefulness of monitoring nocturnal behaviors in adults with NREM sleep parasomnias with an infrared camera in the home environment for 5 and 2 weeks, respectively [21,79].”
BackgroundSelf-citationRestricted truncal sagittal movements of rapid eye movement behaviour disorder
Wasserman, D., Gullone, S., Duncan, I., Veronese, M., Gnoni, V., Higgins, S., Birdseye, A., Gelegen, E. C., Goadsby, P. J., Ashkan, K., et al. (2022) · npj Parkinson's Disease · doi:10.1038/s41531-022-00292-0 · Cited by 18 · cited 1×
“Contrary to REM sleep behavior disorder (RBD), eyes during DoA episodes are wide open [26], even during minor episodes, and movements more often involve the trunk [27].”
Kobayashi, N., Yoshimura, R., & Takano, M. (2012) · Case Reports in Medicine · doi:10.1155/2012/893681 · Cited by 17 · cited 12×
“The efficacy of Clonazepam has also been occasionally described in some cases of DoA induced by neuroleptics [102] and in cases of sleep-driving and violent behaviors [16,100].”
BackgroundInfluentialSexsomnia: Parasomnia associated with sexual behaviour during sleep
Ariño, H., Iranzo, Á., Gaig, C., & Santamaría, J. (2014) · Neurología (English Edition) · doi:10.1016/j.nrleng.2013.01.003 · Cited by 17
Khawaja, I. S., Hurwitz, T. D., & Schenck, C. H. (2017) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.6560 · Cited by 17 · cited 1×
“In some cases, the resolution of comorbid sleep apneas was sufficient to obtain full remission [174,180,181], while other cases required a multi-modal therapeutical approach, including pharmacotherapy, cognitive behavioral therapy, and hypnosis [179].”
BackgroundSleep-related eating disorder associated with zolpidem: cases compiled from a literature review
Ho, T., Jimenez, A., Sanchez, I., Seeger, C., & Joseph, M. (2020) · Sleep Medicine: X · doi:10.1016/j.sleepx.2020.100019 · Cited by 17 · cited 1×
“The relationship between SRED and DoA is suggested by the fact that SRED patients display: (1) a high frequency of past or current SW, which is the predominant sleep disorder associated with night-eating [155]; (2) eating episodes during the first half of the night; (3) several arousals from SWS sleep [156]; (4) the a…”
BackgroundLopez, R., Lefevre, L., Barateau, L., Micoulaud-Franchi, J.-A., Dauvilliers, Y., & Schenck, C. H. (2022) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.9654 · Cited by 17 · cited 2×
“VPSG is usually performed when evaluating patients with atypical NREM sleep parasomnias, meaning cases with red flags, such as (1) adult onset; (2) stereotypical, repetitive, abnormal unnatural postures, ballistic movements or focal motor patterns; (3) high episode frequency; (4) episodes of brief duration; (5) episod…”
BackgroundSchenck, C. H. (2022) · Sleep and Breathing · doi:10.1007/s11325-022-02574-6 · Cited by 17 · cited 1×
“DoA must be differentiated by a number of other sleep disorders [81] (see Table 6): REM-related parasomnias, like nightmare disorder, RBD, and parasomnia overlap disorder [82].”
BackgroundMedications as a Trigger of Sleep-Related Eating Disorder: A Disproportionality Analysis
Merino, D., Gérard, A. O., Van Obberghen, E. K., Ben Othman, N., Ettore, E., Giordana, B., Viard, D., Rocher, F., Destere, A., Benoit, M., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11133890 · Cited by 17 · cited 1×
“While the Z-drug Zolpidem has a relatively high risk of inducing a NREM parasomnia episode [6,96,97], especially in predisposed subjects, low to moderate doses of benzodiazepines (BDZ)—and especially of the long-acting Clonazepam (0.”
BackgroundSexsomnia. Una forma de parasomnia con conductas sexuales durante el sueño
Ariño, H., Iranzo, Á., Gaig, C., & Santamaría, J. (2013) · Neurología · doi:10.1016/j.nrl.2013.01.013 · Cited by 16
Loddo, G., La Fauci, G., Vignatelli, L., Zenesini, C., Cilea, R., Mignani, F., Cecere, A., Mondini, S., Baldelli, L., Bisulli, F., et al. (2021) · Sleep Medicine · doi:10.1016/j.sleep.2021.01.037 · Cited by 16
Self-citationKalantari, N., McDuff, P., Pilon, M., Desautels, A., Montplaisir, J.-Y., & Zadra, A. (2022) · Sleep Medicine · doi:10.1016/j.sleep.2021.12.008 · Cited by 15 · cited 2×
“Of note, the recall rate seems to differ between children and adults, in line with the hypotheses of more immature sleep mechanisms in children (and lower dream recall rate), and with an easier arousability in adults (that may facilitate the incorporation of the dream experience in longterm memory) [5,20].”
BackgroundResultBehavioral Interventions for Parasomnias
Owens, J., & Mohan, M. (2016) · Current Sleep Medicine Reports · doi:10.1007/s40675-016-0046-z · Cited by 14 · cited 1×
“When the occurrence of DoA episodes is highly predictable, arousing the patient 15–20 min prior to the usual onset of a typical episode for 1 to 4 weeks may induce sustained positive results, at least in children with SW [131], ST [132], or CA [133,134].”
BackgroundMeira e Cruz, M., & Soca, R. (2016) · Sleep Science · doi:10.1016/j.slsci.2016.11.002 · Cited by 14
Interobserver reliability of ICSD-3 diagnostic criteria for disorders of arousal in adults
Loddo, G., Vignatelli, L., Zenesini, C., Lusa, F., Sambati, L., Baldelli, L., Favoni, V., Pisani, L. R., Pierangeli, G., Cevoli, S., et al. (2019) · Sleep and Breathing · doi:10.1007/s11325-019-01937-w · Cited by 14 · cited 1×
“This questionnaire has a good interobserver reliability [39], an acceptable sensitivity and a high specificity for the diagnosis of DoA.”
BackgroundSelf-citationMainieri, G., Loddo, G., Castelnovo, A., Balella, G., Cilea, R., Mondini, S., Manconi, M., & Provini, F. (2022) · Nature and Science of Sleep · doi:10.2147/nss.s360120 · Cited by 14 · cited 3×
“This pattern does not seem to differ between simpler or complex DoA behaviors [57], and qualitatively resembles the pattern observed prior to physiological arousals—although perhaps richer in SWA and poorer of higher (beta) activity [59].”
BackgroundSelf-citationSexsomnia: case based classification and discussion of psychosocial implications.
(2021) · PubMed Central · doi:10.5935/1984-0063.20200057 · Cited by 14 · cited 1×
“The prevalence of the disorder is unknown and likely underestimated, since patients may be unaware of their disorder and/or may be psychologically ashamed to the point of avoiding medical help [172].”
BackgroundAttenuation of drug-induced anxiety dreams and pavor nocturnus by benzodiazepines
Allen, R. M. (1983) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198308000-00018 · Cited by 13 · cited 1×
“More anecdotical and sometimes contradictory results are available for other BDZ, like Alprazolam [100,101], Triazolam [103], Temazepam [101], Flurazepam [50], Clorazepate [104], and Diazepam [104–106].”
ResultNREM Parasomnias: Retrospective Analysis of Treatment Approaches and Comorbidities
Limbekar, N., Pham, J., Budhiraja, R., Javaheri, S., Epstein, L. J., Batool-Anwar, S., & Pavlova, M. (2022) · Clocks & Sleep · doi:10.3390/clockssleep4030031 · Cited by 13 · cited 2×
“A surprisingly higher response rate (88%) was reported by another recent smaller retrospective study (8 patients treated with Melatonin—although the formulation was not specified) [98].”
BackgroundResultSuccessful treatment of severe parasomnias with paroxetine in a 12-year-old boy
Frölich, A. W. (2001) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/136515001317021707 · Cited by 12
A Novel Group Cognitive Behavioral Therapy Approach to Adult Non-rapid Eye Movement Parasomnias
O'Regan, D., Nesbitt, A., Biabani, N., Drakatos, P., Selsick, H., Leschziner, G. D., Steier, J., Birdseye, A., Duncan, I., Higgins, S., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.679272 · Cited by 12 · cited 1×
“The authors found a significant, although small, effect on the severity (but not the frequency) of parasomnia symptoms, sleep quality and anxiety/depressive symptoms [151].”
BackgroundKramer, R. L. (1989) · International Journal of Clinical and Experimental Hypnosis · doi:10.1080/00207148908414482 · Cited by 10
Brás, A., Maranci, J., Yang, Z., Chaumereuil, C., & Arnulf, I. (2021) · Sleep Medicine · doi:10.1016/j.sleep.2021.11.012 · Cited by 10
Transdiagnostic cognitive behavioral therapy for nightmares and parasomnias
Vincent, N., Dirkse, D., Giannouli, E., & McQuarrie, A. (2023) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.10374 · Cited by 10 · cited 1×
“More recently, a randomized controlled trial on a CBT protocol specifically developed for parasomnias (CBTp) produced statistically significant improvements in parasomnia frequency, severity, as well as in sleep continuity [152].”
BackgroundA Case of Successful Use of Hypnosis in the Treatment of Parasomnia Overlap Disorder
Kohler, W. C., Kurz, P. J., & Kohler, E. A. (2015) · Behavioral Sleep Medicine · doi:10.1080/15402002.2014.898304 · Cited by 8 · cited 1×
“Hypnotherapy received specific attention since the earliest definition of DoA, with case reports and small case series on SW in adults [138,139], ST or other complex dangerous behaviors in children [140–143], and more recently, even in a case of childhood parasomnia overlap disorder (POD) [144].”
BackgroundDisorders of arousal in 4 older men: Evidence from clinical practice
Loddo, G., Fragiacomo, F., Mainieri, G., Mondini, S., Buzzi, G., Calandra-Buonaura, G., & Provini, F. (2022) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.9516 · Cited by 7 · cited 2×
“VPSG assumes an i portant role in the differential diagnosis between DoA and SHE [35], RBD or parasomnia overlap disorder [42], as well as in sleep-related (psychogenic)”
BackgroundSelf-citationThe treatment of persistent night terrors with autogenic training: A case study
Sadigh, M. R., & Mierzwa, J. A. (1995) · Biofeedback and Self-Regulation · doi:10.1007/bf01474513 · Cited by 6 · cited 1×
“The efficacy of other relaxation techniques such as autogenic training and the psychodynamic approach to emotional conflicts (related to parasomnia behaviors themselves or external factors, considered as triggers of parasomnia episodes) have been sporadically reported [148,149].”
BackgroundKomada, Y., Breugelmans, R., Fulda, S., Nakano, S., Watanabe, A., Noda, C., Nishida, S., & Inoue, Y. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s95681 · Cited by 6
(2021) · PubMed Central · doi:10.5935/1984-0063.20210018 · Cited by 5 · cited 4×
“Comorbid sleep conditions that may act as triggers for sexsomnia episodes include obstructive sleep apneas, PLM, sleep bruxism, or even sleep-related head jerks [173,174,177,178].”
BackgroundInfluentialSuccessful Treatment of Somnambulism with OROS-Methylphenidate
Nigam, M., Zadra, A., Boucetta, S., Gibbs, S. A., Montplaisir, J., & Desautels, A. (2019) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.8040 · Cited by 4 · cited 3×
“Curiously, osmotic release oral system methylphenidate (OROS-MPH) was anecdotally reported to be effective in two adult SW cases with no comorbid ADHD [122].”
BackgroundIntegrative behavioral treatment for NREM parasomnias: A case series
Mundt, J. M., & Baron, K. G. (2021) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.9186 · Cited by 4 · cited 1×
“Interventions ranged from education about parasomnias and their precipitating factors, mitigation of environmental triggers to stress management, cognitive-behavioral interventions focused on parasomnia-related anxiety, and hypnosis [150].”
BackgroundComparing symptom networks of daytime and nocturnal panic attacks in a community-based sample
Smith, N. S., Bauer, B. W., & Capron, D. W. (2022) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2021.102514 · Cited by 4
Proserpio, P., Terzaghi, M., Manni, R., & Nobili, L. (2022) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2022.06.004 · Cited by 4 · cited 2×
“Pharmacologic treatment is generally considered in case of frequent episodes, despite the resolution and removal of all possible priming and precipitating factors for severe episodes (violent or non-violent behaviors, dangerous for the patient or others and/or with potential legal consequences, significant functional…”
BackgroundSelf-citationSexsomnia can be triggered by sleep-related head jerks
Bušková, J., Piorecký, M., & Měrková, R. (2022) · Sleep Medicine · doi:10.1016/j.sleep.2022.02.012 · Cited by 4
Psychobiological personality traits of children and adolescents with disorders of arousal
Turner, K., Castelnovo, A., Perogamvros, L., Cloninger, R. C., Galbiati, A., Bertolotti, A., Proserpio, P., Terzaghi, M., Manni, R., Ferini Strambi, L., et al. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.12.035 · Cited by 4
Self-citationHypnotic Treatment of Sleep-Terror Disorder
Kraft, T. (1990) · American Journal of Clinical Hypnosis · doi:10.1080/00029157.1990.10402921 · Cited by 3 · cited 1×
“In selected cases, the treatment of specific underlying psychopathology may improve parasomnia symptoms [129], although this possibility requires further confirmation.”
Background
Research works printed but not linked: 2
- Kennedy, 2002, A review of hypnosis in the treatment of parasomnias: Nightmare, sleepwalking, and sleep terror disorders, Aust. J. Clin. Exp. Hypn., 30, 99
- Howsam, 1999, Hypnosis in the treatment of insomnia, nightmares, and night terrors, Australian Journal of Clinical and Experimental Hypnosis, 27, 32
Cited by
Behavioral and psychological treatments for NREM parasomnias: A systematic review
Mundt, J. M., Schuiling, M. D., Warlick, C., Dietch, J. R., Wescott, A., Hagenaars, M. A., Furst, A. J., Khorramdel, K., & Baron, K. G. (2023) · Sleep Medicine · doi:10.1016/j.sleep.2023.09.004 · Cited by 24
“Recommendations which commonly appear in previously published non-systematic reviews include ensuring safety, providing reassurance of the time-limited and benign nature of symptoms, improving sleep hygiene, and addressing priming and precipitating factors [2,4,5,7,8,13 – 18].”
Challenges in diagnosing NREM parasomnias: Implications for future diagnostic classifications
Lopez, R., & Dauvilliers, Y. A. (2023) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2023.101888 · Cited by 21
Vasiliu, O. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1393337 · Cited by 21
Conscious experiences during non-rapid eye movement sleep parasomnias
Castelnovo, A., Siclari, F., Spaggiari, S., Borth, D., Manconi, M., Arnulf, I., & Schenck, C. H. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105919 · Cited by 18
Self-citationCastelnovo, A., Schraemli, M., Schenck, C. H., & Manconi, M. (2024) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2024.101898 · Cited by 13
Self-citation
Metadata
- Authors
- Mainieri, G., Loddo, G., Provini, F., Nobili, L., Manconi, M., & Castelnovo, A.
- Affiliations
- University of Bologna (IT)
- Azienda USL di Bologna (IT)
- Istituto delle Scienze Neurologiche di Bologna (IT)
- Istituto Giannina Gaslini (IT)
- University Hospital of Bern (CH)
- University of Bern (CH)
- Corresponding author
- Mainieri, Greta
- Castelnovo, Anna
- Venue
- Diagnostics
- Publisher
- MDPI AG
- Published
- 2023-03-27
- Volume
- 13
- Issue
- 7
- Pages
- 1261
- ISSN
- 2075-4418 (ISSN-L)
- PMC
- PMC10093221
- OpenAlex
- W4361224412
- Cited by
- 34
- References
- 193
- Citations by year
- 2026: 12 · 2025: 9 · 2024: 9 · 2023: 4
- FWCI
- 1.44
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Diagnostics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- BORIS (University Library Bern) (submittedVersion, cc-by)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
- Open Access CRIS of the University of Bern
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
- Health Sciences › Medicine › Clinical Neurology › Restless Legs Syndrome Research
- Keywords
- arousal disorders, diagnostic criteria, video-polysomnography, home video recording, diagnostic certainty, children and adults
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
